Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:36 PM
Ignite Modification Date:
2025-12-24 @ 3:36 PM
NCT ID:
NCT04514692
Eligibility Criteria:
Inclusion Criteria:
* Gynecologic cancer patients receiving pelvic radiation and chemotherapy, specifically: 1) Stage I-IIIC1 cervix cancer, 2) stage I-III primary vaginal cancer, 3) stage IIIA-IIIC1 endometrial cancer patients status post hysterectomy and lymph node assessment, and 4) recurrent endometrial cancer patients with pelvic confined disease No required para-aortic or extended field radiation
* Age \> 18 years
* ECOG performance status 0-2
* Adequate kidney function (serum Cr \<1.5 or creatinine clearance \>50 mg/dl)
* Adequate bone marrow function (white blood cells \> 3.0 X 10\^9/L, platelets \>100 x 10\^9/L)
* Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria:
* Treatment for other cancer in the past 2 years
* Previous pelvic radiation
* Medical condition that prevents receiving chemotherapy
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT04514692
Study Brief:
Protocol Section:
NCT04514692